Medindia

X

New Welsh 'Self-Test' to Cure Glaucoma, the Leading Cause of Preventable Blindness

Tuesday, April 1, 2008 General News J E 4
Advertisement
MIAMI, March 31 According to the World HealthOrganization, more than five million people, mostly elderly blacks, but manyLatinos and a few elderly Whites with their Glaucoma family members,needlessly suffer horribly from total incurable Glaucoma-Blindness("White-Canes"). Most lack the opportunity to get tested for Earlier Glaucomabefore Glaucoma slowly robbed them of all their sight. Dr. Robert Welsh, aRotarian, a world-renowned Eye Surgeon and a leading Medical Missionary canhelp prevent 80,000 new totally blind Glaucoma cases a year throughadministering his new unique invention: The Welsh Glaucoma "Self-Test," andthe New Welsh "T.V. Self-Test for Earlier Glaucoma," on all USA T.V. Stations.

Dr. Welsh said, "Elderly blacks are nine times more gene prone todeveloping blinding Glaucoma than other population groups where the severethreat of new total blindness from chronic Glaucoma can run as high as 80,000newly blind cases per year. Early Glaucoma diagnosis and treatment can be madeby working with Pastors at black churches throughout America."

The Newest Welsh "Self-Test" for Earlier Glaucoma may be awkward, but isalso accurate. It involves holding one hand over the opposite eye and thenusing the free hand for "Finger-Wiggling," testing motion nasally in the eye,staring laterally, to detect reduced or lost "Nose Side Side-Vision," called a95% Glaucoma diagnostic "Nasal-Step" loss. Nasal Steps should be either 80%above 180-degrees or below 15%. No insurance pays for Gross-Field Testing.Most Glaucoma experts and Glaucoma advisors have almost zero experience inGross-Field Testing.

The new Welsh "Self-Test" for Glaucoma can be administered and explainedon all USA T.V. Stations as the new "Welsh T.V. Self-Test" for EarlierGlaucoma and also used in 13,000 US black churches with simple Self-Testinstructions from their Pastors. Pastors can scan their elderly blackcongregation in five minutes after sermons or during special events. Thosefound to be at risk from high pressure Glaucoma are then referred to an areaOphthalmologist (an M.D. Eye) for proper treatments.

Blinding Glaucoma is often called the "Sneak Thief of Sight" because mostBlacks with Advanced Blinding Glaucoma are completely unaware that their"Side-Vision" is being stolen from them until it is too late. Optic-nervedamage due to increased pressure within the eye builds to a point of noreturn. This total incurable blindness in Blacks doesn't have to happen andit won't with the newest Welsh Glaucoma "Self-Test" for mass diagnosis coupledwith treatments including: eye drops, four different types of lasers, andcareful surgery. Avoid "flat-chambers" with Dr.Welsh's "Binocular Patching"for 4-days after any Glaucoma-filtering surgery. (A 100% cure)

Interested Pastors and churches or T.V. Stations may contact Dr. Welsh(305-661-4363) to help stop preventable blindness from earlier treatableGlaucoma or call Bud Grant at 1-516-327-2236 Director of U.S. Congress's newand highly-funded "Glaucoma-Black-Caucus Foundation."

To help prevent Glaucoma blindness, copy this document and send to Pastorsof black churches in your area and/or to all churches and T.V. Stations aroundthe U.S.A.

Dr. Welsh is the author of eight books on eyesight and the man behind thenow famous biennial Welsh Cataract Congresses which met from 1969 to 1996. Heis now retired but working for free.

CONTACT: Dr. Robert Welsh, MD-Eye at 1135 Campo Sano Avenue Coral Gables,FL 33146 Phone/Fax: 305-661-4363; http://www.glaucomaselftest.org/

SOURCE Dr. Robert Welsh, MD-Eye
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Landmark Trial ONTARGET(R) Proves Telmisartan is a...
S
Landmark ONTARGET(TM) Trial Demonstrates Micardis(...